Nervgen Pharma Corp (NGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2006 | 06-2006 | 03-2006 | 12-2005 | 09-2005 | |
| Assets | |||||
| Current Assets | |||||
| Other current assets | 2,120 | 2,050 | 1,870 | 1,450 | 1,850 |
| TOTAL | $2,120 | $2,050 | $1,870 | $1,450 | $1,850 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 64,340 | 64,630 | 56,130 | 50,780 | 110,030 |
| TOTAL | $64,340 | $64,630 | $56,130 | $50,780 | $110,030 |
| Total Assets | $66,460 | $66,680 | $58,000 | $52,230 | $111,880 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 680 | 640 | 640 | 700 | 720 |
| Accounts payable and accrued liabilities | 11,380 | 10,480 | 7,810 | 7,720 | 7,270 |
| Other current liabilities | 6,280 | 3,260 | 700 | 620 | 700 |
| TOTAL | $18,340 | $14,380 | $9,150 | $9,040 | $8,690 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 24,320 | 7,660 | 6,930 | 6,640 | 6,240 |
| TOTAL | $24,320 | $7,660 | $6,930 | $6,640 | $6,240 |
| Total Liabilities | $42,660 | $22,040 | $16,080 | $15,680 | $14,930 |
| Shareholders' Equity | |||||
| Common Shares | 60 | 60 | 60 | 50 | 50 |
| Other shareholders' equity | -5,210 | -540 | -7,140 | -9,190 | -9,440 |
| TOTAL | $422,610 | $420,540 | $405,410 | $386,150 | $385,620 |
| Total Liabilities And Equity | $465,270 | $442,580 | $421,490 | $401,830 | $400,550 |